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Abstract
The DNA Topoisomerase I enzyme of Mycobacterium tuberculosis (MtTOP1) is
essential for the viability of the organism and survival in a murine model. This
topoisomerase is being pursued as a novel target for the discovery of new therapeutic
agents for the treatment of drug resistant tuberculosis (TB). In this study, we
succeeded in obtaining a structure of MtTOP1 by first predicting that the C-terminal
region of MtTOP1 contains four repeated domains that do not involve the Zn-binding
tetra-cysteine motifs seen in the C-terminal domains of E. coli topoisomerase I. A
construct (a.a. A2-T704), MtTOP1-704t, that includes the N-terminal domains (D1-D4)
and the first predicted C-terminal domain (D5) of MtTOP1 was expressed and found to
retain DNA cleavage-religation activity and catalyze ssDNA catenation. MtTOP1-704t
was crystallized, and a structure of 2.52 Å resolution limit was obtained. The structure of
the MtTOP1 N-terminal domains has features that have not been observed in the other
previously available bacterial topoisomerase I crystal structures. The first C-terminal
domain D5 forms a novel protein fold of a four-stranded antiparallel -sheet stabilized
by a crossing-over -helix. Since there is only one type IA topoisomerase present in
Mycobacteriaceae and related Actinobacteria, this subfamily of type IA topoisomerase
may be required for multiple functions in DNA replication, transcription, recombination,
and repair. The unique structural features observed for MtTOP1 may allow these
topoisomerase I enzymes to carry out physiological functions associated with
topoisomerase III enzyme in other bacteria.
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Introduction
Topoisomerases are needed in all organisms to maintain the optimal level of
DNA supercoiling for physiological functions, and to resolve topological barriers
encountered during processes of replication, transcription, recombination, and repair.1, 2
In most organisms, multiple topoisomerases are present, and each cellular
topoisomerase has specific roles associated with these physiological processes.3 The
genome of the pathogen Mycobacterium tuberculosis encodes only one type I
topoisomerase that catalyzes topological transitions by cutting and rejoining a singlestrand of DNA and one type II topoisomerase that carries out catalysis by cutting and
rejoining a double-strand of DNA. The type II topoisomerase (DNA gyrase) of M.
tuberculosis is the target of moxifloxacin, a fluoroquinolone antibacterial agent being
utilized in a new tuberculosis (TB) drug combination regimen and found to be beneficial
for reducing TB treatment duration.4 The only type I topoisomerase in M. tuberculosis
(MtTOP1, Rv3646c) is a type IA topoisomerase that has been found to be essential for
growth, and its depletion was shown to decrease survival following treatment with
novobiocin and isoniazid.5 Each year, around 9 million people worldwide develop TB
caused by Mycobacterium tuberculosis, accounting for 1.3 million deaths. MtTOP1 has
been actively investigated as a target for novel TB drugs6-8 that are very much needed
for the treatment of drug-resistant TB. The structure of MtTOP1 will be essential for
structure-based rational drug discovery efforts.
Our early trials to obtain diffraction quality crystals of the full length MtTOP1
protein were unsuccessful. Constructs of the MtTOP1 N-terminal region corresponding
to the N-terminal domains D1-D4 found in E. coli topoisomerase I (EcTOP1) crystal
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structures did not express well as soluble proteins. In a recently determined structure of
full length EcTOP1 in complex with ssDNA9 (PDB ID: 4RUL), the C-terminal region of
EcTOP1 comprises three 4-Cys zinc ribbon domains and two zinc ribbon-like domains,
and a modular ssDNA-binding mode was observed. This suggests that the C-terminal
region of MtTOP1 may also contain multiple domains with repeated and conserved
sequence motifs even though the sequences of EcTOP1 and MtTOP1 C-terminal
regions are very different with essentially no homologies. We analyzed the structural
aspects of the C-terminal region of MtTOP1. The recognition of individual domains in
this region helped us redesign constructs for functional studies and enabled us to obtain
diffraction quality crystals for structural characterization of MtTOP1. We report here the
crystal structure of MtTOP1-704t with the N-terminal domains D1-D4 and C-terminal
domain D5 (a.a. A2-T704) and its functional characterizations.

Results
Analysis of C-terminal domains of MtTOP1
MtTOP1 does not have easily recognizable sequence motifs (such as the
repeated 4-Cys Zn-binding motifs present in EcTOP1) that can help divide the MtTOP1
C-terminal region into domains. Nevertheless, MtTOP1 does bear four GxxGPY
sequence motifs10 in its C-terminal region. Based on the locations of the four GxxGPY
repeats, we divided the region into four repeat domains (Fig. 1). A secondary structure
prediction indicated that each domain comprises three or four β-strands and one Cterminal α-helix.11 The predicted folding of the MtTOP1 C-terminal domains is different
from the zinc ribbon domains or zinc ribbon-like domains found in EcTOP1 and
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Thermotoga maritima topoisomerase I.12 After the fourth or last C-terminal domain
there is an additional long highly positively charged tail (~ 26 amino acids) in MtTOP1.
Besides the basic C-terminal tail, there are two more stretches of basic amino acids.13
Based on the prediction, one is a part of the insertion on the loop between the 3 and
4 strands of D6, and the other is a part of the linker between the D7 and D8 domains
(Fig. 1). Deletions of the stretches of basic amino acids in the C-terminal region of
MtTOP1 have been shown to affect DNA binding and DNA strand passage.13 The
deletions would unlikely make an impact on the folding of the individual C-terminal
domains but may affect the relative orientations of the C-terminal domains and the interdomain flexibility.
MtTOP1-704t is one of the constructs that have been made based on the Cterminal domain prediction above. It spans from amino acid A2 to T704 and includes
the N-terminal domains and the first predicted C-terminal domain D5 (Fig.1 and
Graphical Abstract). The functional and structural characterization of MtTOP1-704t is
the focus of this study.

Biochemical activities of MtTOP1-704t
MtTOP1-704t can be expressed readily as a soluble recombinant protein in E.
coli host strain T7 Express Crystal. The protein was purified to >99% homogeneity and
assayed for relaxation of negatively supercoiled plasmid DNA. The results in Fig. 2
showed that while relaxation activity can be detected with 6.2 ng (60 fmole) of the full
length MtTOP1, relaxation activity was not observed with 100 ng (1.3 pmole) of
MtTOP1-704t.

6

Although relaxation activity could not be detected for MtTOP1-704t, the protein
was found to have DNA cleavage activity similar to that of full length MtTOP1 (Fig. 3A).
The same preferred cleavage site with a cytosine base that is four nucleotides upstream
of the cleavage site was recognized for formation of the cleavage product.14
Intramolecular religation was promoted by adding Mg(II) to shift the cleavage-religation
equilibrium toward religation along with 1 M NaCl to dissociate the non-covalent
enzyme-DNA complex. The results in Fig. 3B showed that MtTOP1-704t is efficient in
DNA religation, so the C-terminal sequences not found in MtTOP1-704t do not affect the
cleavage and rejoining of ssDNA by MtTOP1.
There are two types of IA topoisomerases in most species of bacteria that have
been studied. E. coli topoisomerase III (EcTOP3) is much more efficient than EcTOP1
in DNA catenation/decatenation, while EcTOP1 can remove negative supercoils much
more rapidly.15 Since M. tuberculosis only has one type of IA topoisomerase enzyme,
MtTOP1 is likely to be required for the resolution of single-stranded DNA recombination
and replication intermediates. The catenation activity of Mycobacterium smegmatis
topoisomerase I has been demonstrated previously with M13 single-stranded DNA.16
Since MtTOP1-704t was found to have robust DNA cleavage-religation capabilities, the
truncated enzyme was assayed for catenation of single-stranded M13mp18 DNA circles
to determine if it can catalyze passage of a single-stranded DNA through the break
created by enzyme cleavage on another single-strand. The results (Fig. 4) showed that
MtTOP1-T704 has comparable catenation activity to that of full length MtTOP1.

Overall structure of MtTOP1-704t
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The crystal structure of MtTOP1-704t was determined with molecular
replacement17 and alternative cycles of model building and refinement (Table 1). In the
asymmetric unit, there is one MtTOP1-704t as shown in Fig. 5. The 15 N-terminal
residues (A2 to S16) are not visible in the electron density maps of the structure. This
indicates the flexible nature of the N-terminal leading peptide, and the flexibility is
consistent with its glycine-rich (five Gly residues) composition. Interestingly, the first 15
residues (A2 to S16) of the peptide are “extra” compared to EcTOP1, Fig. 6.
Additionally, the leading peptide is positively charged (including one Arg and two Lys
residues, Supplementary Fig. 1). The functionality of this leading peptide is currently
unknown.
The model of the crystal structure of MtTOP1-704t starts from G17, which
corresponds to the starting residue G2 of the EcTOP1 structure (Fig. 6). There is no
indication for a stable quaternary assembly based on a PISA (Protein, Interface,
Structures, and Assemblies) analysis,18 which is consistent with the observation that
MtTOP1 is a monomer in solution. The four N-terminal domains (D1-D4, G17-A638)
have a similar toroid assembly as EcTOP1 (G2-N590) while the first C-terminal domain
D5 shows sequential and structural novelties among known protein folds as discussed
later.
To evaluate the similarity of the N-terminal assembly of MtTOP1 to that of
EcTOP1, the N-terminal domains of these two molecules were aligned,19 resulting in a
root mean square deviation (rmsd) of 1.92 Å and sequence identity of 44.9% (Fig.7A).
Pair-wise alignments of individual domains resulted in rmsd values of 1.01 Å, 1.46 Å,
1.35 Å, and 1.39 Å for D1, D2, D3, and D4, respectively. Their sequence identities are
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56.0%, 26.9%, 49.6%, and 49.2%, respectively. Apparently, D1 is the most conserved
while D2 is the least conserved between MtTOP1 and EcTOP1.
Similarly, when the N-terminal region of MtTOP1 is superimposed on EcTOP3
(Fig. 7B), the calculated rmsd value was 3.66 Å with a sequence identity of 21.5%.
Relative domain-domain movement of these enzymes in their crystals could impact the
superposition involving multiple domains. Pair-wise individual domain alignments of
MtTOP1 and EcTOP3 yielded rmsd values of 1.76 Å, 1.93 Å, 2.11 Å, and 1.85 Å for D1,
D2, D3 and D4, respectively. Their sequence identities are 28.3%, 19.5%, 31.3%, and
25.2%, respectively. From these comparisons it is clear that MtTOP1 is closer to
EcTOP1 than EcTOP3. However, MtTOP1 has some local structural features similar to
EcTOP3, to be elaborated on later. There is no metal binding observed at the active
site of the Apo form of MtTOP1.

Unique features of individual N-terminal domains of MtTOP1
The D1 or so called TOPRIM (TOpoisomerase-PRIMse) domain is the most
conserved domain in the N-terminal region among these enzymes based on the
alignments above. In MtTOP1 it includes residues G17 to D157 except the region from
R50 to S86, which sticks out from D1 toward D4 (colored grey in Fig. 5). In the EcTOP1
structure, a similar protruding region is defined as a part of D4 because of its close
association with the main body of D4 and its partial role in forming a ssDNA-binding
groove on D4.20, 21 For comparison, we define this region in MtTOP1 as a part of D4 as
well, although it is described as a part of D1 in the EcTOP3 structure.22 In MtTOP1, this
protruding region has no sequence homology to the corresponding region in EcTOP1
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and is 15 amino acids shorter (Figs. 5 and 6). Though this protruding region from R50
to S86 does not have a prominent -helix seen in EcTOP1 (Fig. 7A), it is well
structured, comprising five β turns and a short β hairpin. Interestingly, in EcTOP3, this
portion is also a tight loop, similarly consisting of multiple β turns22 (Fig. 7B). The
significance of the structural variation of the protrusion remains unknown.
The hinge domain D2 comprises two sequentially separated regions: F213 to
R302 (β1-β2-α1-β3) and D434 to R516 (β4-β5-α2-β6) (Figs. 5 and 6). Though the
sequence identities of the domain between MtTOP1 and EcTOP1 or EcTOP3 are as
low as 26.9% and 19.5%, respectively, the hinge domain of MtTOP1 essentially has a
similar structure to that of the two E.coli topoisomerases except for two rather prominent
insertions in MtTOP1. The first insertion (T252 to I270, colored magenta in Figs. 5A
and 7) creates a large loop between β2 and α1 on the right side behind the toroid hole.
The magenta loop is rich in charged residues and seemingly creates a positively
charged edge on the top of the toroid hole (Fig. 5). A smaller insertion (loop214-255)
was found in EcTOP3, which forms a helical motif instead (Fig 7B).22 The second
insertion (G480 to A485, colored red in Figs. 5A and 7) is part of a long loop between α2
and β6 in the bottom front of the toroid hole. This loop is negatively charged. The two
charged loops (colored in magenta and red) positioned on the two sides of the toroid
hole of MtTOP1 might play an important coordinating role in the proposed route of the
passing strand during catalysis of DNA relaxation by attracting or repelling DNA. The
magenta colored insertion T252 to I270 is unique to MtTOP1 and EcTOP3 and may
play roles that differentiate MtTOP1 and EcTOP3 from EcTOP1.
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D3 is an all α-helical domain (P303 to A433), including the catalytic residue Y342
on a loop between the α2 and α3 helices. The catalytic site of the Apo form of MtTOP1
centered at Y342 shows no significant conformational variation compared to the
catalytic sites of the Apo forms of either EcTOP123 or EcTOP3,22 indicating the same
catalytic mechanism for these type IA topoisomerases. The catalytic site also includes
the DxDREG TOPRIM sequence motif from D1, which is quite conserved (Fig. 6). The
only difference is the variation in residue x, which is Gly112 in MtTOP1, a Leu in
EcTOP1, and a Pro in EcTOP3. Additionally, between the α3 and α4 helices of D3,
there is a long loop of 35 residues, including the sequence motif Q386EAHEAIRP that is
highly conserved in type IA topoisomerases, with the invariant histidine proposed to play
a role in catalysis24. In all of the EcTOP1 structures determined to date, a part of the
loop upstream of the conserved sequence is partially disordered. In MtTOP1, in
contrast, this loop is well structured without any break and seemingly correlates to the
formation of the α4 helix (highlighted in blue, Fig. 5), which degenerates to a -turn in
EcTOP1 (Fig. 7A).
In MtTOP1, a feature of D4 may be related to one of its physiological functions;
the last helix in D4 (α8) has an insertion of 14 residues (G610 to G623, colored purple in
Figs. 5 and 7) in the middle of the helix, which is not found in EcTOP1 and EcTOP3.
The purple insertion is right below the decatenation loop of EcTOP3,22 which is also
from D4 (Fig. 7B). The actual functionality of this unusual insertion in the α8 helix needs
to be explored. The α8 helix is then followed by a linker to the C-terminal domains. The
linker is very different in sequence and structure among MtTOP1, EcTOP1, and
EcTOP3, indicating the connection between the N- and C-terminal domains varies
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significantly among these topoisomerases. However, the DNA-binding groove is mostly
conserved (Fig. 5). Two negatively charged sulfate groups likely from the
crystallization buffer were identified inside the positively charged DNA-binding groove
(not shown). They may mimic two phosphate groups of DNA in their interactions within
the groove.

Novel MtTOP1 C-terminal domain
D5 is the first C-terminal domain, from R638 to P705. This small domain of 67
residues is composed of a four-stranded antiparallel β-sheet with a C-terminal helix
packed against the β-sheet on one side (Fig. 8). Hydrophobic interaction dominates the
interaction between the β-sheet and the helix. An additional salt bridge (R668-E699)
and hydrogen bonds are also observed. The helix apparently plays an important role in
stabilizing the β-sheet and the small domain. The other side of the β-sheet is open and
hosts several residues that may be involved in DNA binding. The conserved tyrosine
Y665, the third residue of the β3-strand, could be a key residue in the interaction of D5
with DNA by forming π–stacking(s) with the base(s) of DNA (Fig. 5). The other residues
Y656 and R658 on the β2-strand, R681 on the β4-strand and K661 on the sharp β2-β3
turn (Fig. 5) can potentially form π–stacking, π–cation, or other forms of interaction with
DNA.
A Dali structural homology search25 of MtTOP1 results in no significant hits (Z
score ≤ 4.3, rmsd ≥ 2.6, and sequence identity ≤ 14%) even though a protein fold
containing a helix packed against one face of an anti-parallel -sheet is common. This
indicates the structural novelty of the MtTOP1 C-terminal domain.

12

Classification of topoisomerase C-terminal domains.
From Fig. 1, it is clear that the four MtTOP1 C-terminal domains exemplified by
D5 represent one subgroup (Topo_C_Rpt) of bacterial topoisomerase C-terminal
repeats. In this subgroup a C-terminal domain has a four-stranded antiparallel β-sheet
compounded or stabilized by a crossing-over α-helix on one side of the β-sheet.
Besides MtTOP1, Topo_C_Rpt can also be found in other Mycobacterium species as
well as related species of Actinobacteria (Supplementary Fig. 1). The second subgroup
of the C-terminal domain of topoisomerases, namely Topo_C_ZnRpt, is represented by
the 4-Cys zinc ribbon domains of EcTOP1, in which one four-stranded antiparallel βsheet is stabilized by a Zn-binding site on the top of each domain9 (PDB ID: 4RUL).
Variations of these two subgroups or even new subgroups are expected with further
structural characterization of topoisomerases. For example, the only C-terminal domain
of Thermotoga maritima topoisomerase I can be regarded as a member of
Topo_C_ZnRpt but without Zn binding.

Discussion
Trapping of the bacterial topoisomerase I covalent complex on cleaved
chromosomal DNA has been shown to result in rapid bacterial cell death, validating this
class of enzyme as a useful target for novel bactericidal antibiotics26, 27. The structure of
MtTOP1-704t reported here provides details of the active site and its vicinity that would
be useful for the discovery of poison-type inhibitors for trapping of the topoisomerase
covalent intermediate. Topoisomerase poisons are typically interfacial inhibitors
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interacting with both DNA and the topoisomerase.28 Interactions between potential
poison-type inhibitors and MtTOP1 protein residues near the active site are needed to
confer high binding affinity and selectivity. For example, while m-AMSA has been
shown to inhibit M. tuberculosis topoisomerase I and growth of M. tuberculosis,29 this
compound has much greater selectivity for eukaryotic type II topoisomerases. A binding
pocket for functional groups in m-AMSA present near the active site of human type II
topoisomerases accounts for the specific interactions with m-AMSA and its
effectiveness as an anticancer drug. The construct of MtTOP1-704t could be utilized in
the future for co-crystallization of an enzyme-DNA-inhibitor ternary complex to further
enable the discovery of new TB therapies.
Catalytic inhibitors of MtTOP1 could also be useful for treating TB by inhibiting
the essential function of the enzyme. MtTOP1-704t has no detectable relaxation
activity. Some or all other C-terminal parts of MtTOP1 including D6, D7, and D8 or
even the flexible tail may be required for relaxation of DNA supercoiling. MtTOP1-704t
can carry out DNA cleavage-religation and catalyze the catenation of ssDNA with
efficiencies comparable to those of full-length MtTOP1. All Mycobacterium species and
most members of the Actinobacteria phylum have only one type IA topoisomerase
encoded in their genomes. These include the topoisomerase I with a domain
organization similar to MtTOP1 found in the pathogens Corynebacterium diphtheria and
Actinomyces odontolyticus (Supplementary Fig. 1) that are likely to also be essential for
viability. Unique features observed in the N-terminal domains of MtTOP1, such as the
charged loops on opposite sides of the toroid hole and the insertion at the position near
where the decatenation loop of EcTOP3 can be found, may also have evolved for
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MtTOP1 to carry out all the catalytic functions that may be associated with bacterial type
IA topoisomerases. Further studies are required to determine the biochemical and
physiological significance of these unique structural features.
The novel structure of the MtTOP1 C-terminal domain D5 reported here provides
new insights into the folding of diverse bacterial topoisomerase I proteins, particularly
their C-terminal regions. The organization of repeated bacterial topoisomerase I Cterminal domains may have arisen during evolution through gene duplication. Gene
segments that encode a specific protein fold that can interact with ssDNA have been
combined in the evolutionary process with the segments encoding the N-terminal
domains that have the DNA cleavage-religation active site at the entrance of a toroid
hole. Different repeats of the Topo_C_Rpt or Topo_C_ZnRpt domains or their
likenesses are utilized in each bacterial species for the DNA-protein or protein-protein
interactions that are required for the catalytic activity and physiological functions of this
ubiquitous enzyme. Interaction between the C-terminal domains of EcTOP1 and RNA
polymerase is important for the efficient removal of transcription-driven negative
supercoiling during transcription elongation.30 The C-terminal domains of MtTOP1 may
interact similarly with M. tuberculosis RNA polymerase for relieving the torsional stress
generated during transcription.
The flexibility of the linkers between the individual C-terminal domains may
account for the difficulty encountered in the crystallization of full-length bacterial
topoisomerase I proteins. This could be addressed by introducing a DNA binding
substrate or protein interaction partner to limit the degree of interdomain movement,
facilitating the crystallization of full length proteins. Successful determination of full-
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length Mycobacterium topoisomerase I crystal structures will provide additional new
insights into the mechanism and function of this essential enzyme.

Materials and Methods
Cloning, expression, and purification
A clone for expression of MtTOP1-704t was constructed using the Gibson
Assembly Master Mix from New England BioLabs, placing the coding sequence of
residues 2-704 of MtTOP1 under the control of the T7 promoter in pET-His6-Mocr TEVLIC cloning vector (2O-T) that was a gift from Scott Gradia (Addgene plasmid # 29710).
The MtTOP1-704t protein was expressed in the E. coli T7 Express Crystal strain (New
England BioLabs). Cells were grown in Luria Bertani broth at 37°C to the exponential
phase (OD600 = 0.4) and left at room temperature for 20 min. Recombinant protein
expression was induced by adding 1 mM IPTG. After overnight induction at 22°C, the
cells were collected and subjected to freeze-thaw lysis in buffer (20 mM sodium
phosphate pH 7.4, 0.5 M NaCl, 20 mM imidazole, 1 mg/ml lysozyme). The recombinant
protein in the soluble lysate was allowed to bind to Ni Sepharose 6 Fast Flow (GE
Healthcare) and packed into a column. After extensive washing with buffer (20 mM
sodium phosphate pH 7.4, 0.5 M NaCl, 20 mM imidazole), the topoisomerase protein
was eluted with buffer (20 mM sodium phosphate, pH 7.4, 0.5 M NaCl, 500 mM
imidazole). Following treatment with TEV protease, the protein was passed through the
Ni Sepharose again to remove the His6-Mocr tag. Additional purification was achieved
with single-stranded DNA cellulose column chromatography (Sigma) using an
increasing concentration gradient of KCl to elute the protein. The final purification step
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utilized an S300 size exclusion chromatography column as described previously.31 The
purified protein was concentrated to about 85 mg/ml for crystallization.

Crystallization
The screening for crystallization conditions was set up with a Mosquito nanoliter liquid
handler (TTP LabTech) using the sitting drop vapor diffusion technique in 96-well
CrystalQuick plates (Greiner). For each condition, 0.2 µl of protein and 0.2 µl of
crystallization formulation were mixed, and the mixture was equilibrated against 140 µl
of the crystallization solution in each reservoir well. The crystallization screens used
were MCSG-1–4 at 16°C. Diffraction quality crystals appeared under the following
condition: 0.2 M Ammonium Sulfate, 0.1 M Tris:HCl pH 8.5, and 25% (w/v) PEG3350.
Prior to data collection, the crystals were treated with cryoprotectant (20% glycerol in
crystallization buffer) and cryocooled directly in liquid nitrogen.

X-ray diffraction and structure determination
Sets of single-wavelength diffraction data were collected at 12.66 keV at 100 K
from cryocooled MtTOP1-704t crystals. All data were obtained at the 19-ID beamline of
the Structural Biology Center at the Advanced Photon Source at Argonne National
Laboratory using the program SBCcollect.32 The intensities of each data set were
integrated, scaled, and merged with the HKL3000 program suite33 (Table 1). The best
data set measured has a resolution limit of 2.52 Å. The structures of the MtTOP1-704t
crystal were determined using the molecular replacement method.17 The best search
template used was the structures of the N-terminal domains (D1-D4) of full-length
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EcTOP1 (PDB ID: 4RUL). Subsequent model rebuilding for the N-terminal domains and
building the first C-terminal domain (D5) based on difference maps was performed
using the program COOT34. After several alternative cycles of model building and
refinement, the final model was refined using the program Phenix.refine35 (Table 1).
Structural validation was performed using the program MolProbity.36

Relaxation activity assay
The relaxation reaction was carried out in 20 µl of 10 mM Tris-HCl (pH 8.0) 50
mM NaCl, 0.1 mg/mL gelatin, and 5 mM MgCl2 with 250 ng of supercoiled pBAD/Thio
plasmid DNA purified by CsCl gradient centrifugation. Following incubation at 37°C for
30 min, the reactions were terminated and analyzed by agarose gel electrophoresis as
previously described.37

Assay of oligonucleotide DNA cleavage and religation
The 32 base oligonucleotide substrate 5’CAGTGAGCGAGCTTCCGCT↓TGACATCCCAATA-3’ with a preferred cleavage site for
MtTOP1 indicated by the arrow has been previously described.13 It was labeled at the
5’-end with γ-32P-ATP and T4 polynucleotide Kinase. Cleavage activity was assayed by
incubating the labeled oligonucleotide (0.5 pmole) with MtTOP1 and MtTOP1-704t in 5
μl of 10 mM Tris-HCl pH 8.0 at 37°C for 30 min. Intramolecular religation was initiated
by addition of MgCl2 followed by further incubation for 15 min. The reactions were
terminated by the addition of an equal volume of sequencing gel loading buffer. The
reaction substrate and the 19 base-long cleavage product were separated by
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electrophoresis in a 15% sequencing gel followed by Phosphor-Imager analysis of the
gel.

Catenation activity assay
Catenation of M13 ssDNA circles was assayed with a protocol similar to
previously described conditions16. The reaction volume of 20 µl contained 20 mM TrisHCl (pH 8.0), 20 mM KCl, 2 mM MgCl2, 0.05 mg/ml BSA, 10 mM spermidine, 30%
glycerol, and 0.5 µg of M13 ssDNA (from Bayou Biolabs). After incubation with the
indicated amount of topoisomerase protein for 1 h at 52°C, the reactions were
terminated with the addition of 1% SDS, 5 mM EDTA, and 12 µg of proteinase K, and
left at 37°C for 1 h before electrophoresis in 0.8% agarose gel.

Accession Number
The atomic coordinates and structure factors of M. tuberculosis topoisomerase I have
been deposited in the Protein Data Bank with accession code 5D5H.
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Figure Legends

Fig. 1. Division of the C-terminal region of M. tuberculosis topoisomerase I into
four domains and a flexible tail. The conserved residues among the four domains are
highlighted in red, including the GxxGPY sequence motif. Besides the conserved
tyrosine residues within the GxxGPY motifs, other possible DNA binding residues are
highlighted in magenta (for possible π stacking to the bases of nucleotides) or blue (for
possible π–cation or salt bridge or hydrogen bond to DNA). The secondary structures
of D5 are indicated above the appropriate sequence of D5. The highly positively
charged tail after D8 is listed below the alignment, and it is presumably structurally
flexible.

Fig. 2. Assay of relaxation activity of full length MtTOP1 and MtTOP1-704t.
Supercoiled pBAD/Thio plasmid DNA was incubated with the indicated amount of
MtTOP1 or MtTOP1-704t at 37°C for 30 min before separation of the supercoiled DNA
from relaxed topoisomers by agarose gel electrophoresis.

Fig. 3. DNA cleavage and religation by MtTOP1-704t (A) Comparison of the
formation of DNA cleavage product by MtTOP1 and MtTOP1-704t. O: Oligonucleotide
substrate; P: Major cleavage product. (B) Intramolecular DNA religation by MtTOP1
and MtTOP1-704t. Lane 1: Oligonucleotide substrate with no enzyme; Lanes 2 and 5:
DNA cleavage reaction. (C) DNA religation (R) with no Mg2+ present; Lanes 3 and 6:
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DNA religation (R) with 5 mM MgCl2 and 1 M NaCl added; Lanes 4 and 7: DNA
religation (R) with 10 mM MgCl2 and 1 M NaCl added.

Fig. 4. Catenation of single-stranded M13mp18 DNA by MtTOP1 and MtTOP1-704t.
Single-stranded M13mp18 DNA was incubated with the indicated amount of MtTOP1 or
MtTOP1-704t before proteinase K treatment. C: circular ssDNA; L: linear ssDNA; CC:
catenated circular ssDNA.

Fig. 5. Structure of MtTOP1-704t. (A) A ribbon diagram of the structure of MtTOP1704t. The main bodies of the N-terminal D1, D2, D3, and D4 domains and the Cterminal D5 domain are colored in salmon, yellow, cyan, green, and pink, respectively.
Numbering of the secondary structures are based on each individual domain. The
protrusion from D1 that is regarded as a part of D4, as described in the EcTOP1
structure, is colored in grey. In D2, the two loops that include unique insertions are
colored in magenta (the loop between β2 and α1) and red (the loop between α2 and
β3). In D3, the α4 helix that degenerated to a β-turn in the EcTOP1 structures is
highlighted in blue. The catalytic residue Y342 is drawn in stick format. In D4, the
unusual insertion in the middle of the α8 helix is highlighted in purple. (B) and (C) The
molecular surface representations of MtTOP1-704t. The orientation of the molecule in
(B) is the same as that in (A). The orientation of the molecule in (C) has a 180° rotation
around the vertical axis with respect to the view in (B). (D) and (E) The electrostatic
potential surface representations of MtTOP1-704t. The surface of MtTOP1-704t is
colored according to amino acid residue charge, ranging from blue (positive) to red
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(negative). The orientation of the molecule in (D) is similar to that in (B), but with a -15°
rotation around the horizontal axis with respect to the view in (B) for a better view of the
DNA binding groove. The orientation of the molecule in (E) is the same as that in (C).
Figures 5, 7, and 8 are prepared with the program PyMOL (http://www.PyMOL.org).

Fig. 6. N-terminal domain arrangement of MtTOP1 and multiple sequence
alignment. (A) The N-terminal domain arrangement of MtTOP1. Domains D1, D2, D3,
and D4 are colored in salmon, yellow, cyan, and green, respectively. The protruded
region from D1 in MtTOP1 and EcTOP1, is regarded as a part of D4. In EcTOP3, it is
described as a part of D1.22 The asterisk indicates the location of the catalytic tyrosine
residue. (B) Structure-based Multiple Sequence Alignment with EcTOP1 and EcTOP3.
The residues that are identical between MtTOP1 and EcTOP1 are colored in red. The
residues of EcTOP3 that are conserved in both MtTOP1 and EcTOP1 are also colored
in red. The residues in regions of similar secondary structures but different
conformations between MtTOP1 and EcTOP1 are colored in green. The residues in
regions with neither sequential nor structural alignments are colored in blue. The
disordered residues in the structures of EcTOP1 are shown in lower case. The
secondary structures of MtTOP1, -helices as coils and -strands as arrows, are drawn
above the appropriate sequence of MtTOP1. The numbering of these secondary
structures is based on each domain for descriptive convenience. The same color
schemes for domains used in (A) are used for highlighting their corresponding
sequences of MtTOP1 and EcTOP1 in the structural alignment.
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Fig. 7. N-terminal region structural alignments of MtTOP1 with EcTOP1 and
EcTOP3. (A) Ribbon diagrams of the superposition of MtTOP1 with EcTOP1 in a front
view and in a side view. The color scheme for the MtTOP1 domains and featured
structural parts is the same as in Fig. 5. EcTOP1 is colored in grey. (B) Ribbon
diagrams of the superposition of MtTOP1 with EcTOP3 in a front view and in a side
view. EcTOP3 is colored in grey, and its decatenation loop is labeled.

Fig. 8. Structure of the first MtTOP1 C-terminal domain (D5). (A) A ribbon diagram
of D5. The residues (G660, G663, and Y665) that are part of the highly conserved
sequence motif GxxGPY in each MtTOP1 C-terminal domain are highlighted in
magenta. Several residues (including Y665) that are potentially involved in DNA
binding are drawn in stick format. (B) A stereo view of the -sheet of D5 and several
exposed residues on the -sheet mentioned in (A). The electron density drawn in grey
mesh is calculated from a weighted 2Fo-Fc map and contoured at the 1 level.
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Table 1: Data collection and refinement statistics
Data collection
Space group
Unit Cell dimensions
a, b, c (Å)
α, β, γ (°)
MW Da (residue)
Mol (AU)
Wavelength (Å)
Resolution (Å)
Number of Unique reflections
Completeness (%)
Redundancy
Rmerge
I/σ(I)
Solvent content (%)
Phasing
Resolution (Å)
Correlation coefficient 3
Refinement
Resolution
No. reflections (work/test)
Rwork/Rfree
No.of atoms
Protein
Water/Others
B-factors (Å2)
Protein
Water/Others
R.m.s deviation
Bond length (Å)
Bond angle (°)
PDB code
1

MtTOP1
P212121
64.00,93.15, 140.2
90, 90, 90
77,468.3 (703) 1
1
0.9792
42.0-2.52
28,858
99.2 (97.6) 2
5.6 (5.6) 2
0.098 (0.696) 2
14.0 (2.0) 2
54.3
42.0-3.00
0.416
42.0-2.52
26,111/1,380
0.174/0.241
5334
72/47
55.0
40.7/77.47
0.008
1.083
5D5H

Not including three N-terminal vector-derived residues, SNA;

2

(Last resolution bin, 2.52-2.56

Å); 3 Molecular replacement
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Highlights


A long-awaited crystal structure of M. tuberculosis Topoisomerase I
(MtTOP1)



Recognition of individual MtTOP1 C-terminal domains and their
organization



Rational design of truncated MtTOP1 enables production of diffraction
quality crystals



Charged loops in the toroid hole are unique features of MtTOP1 N-terminal
domains



Novel protein fold of MtTOP1 C-terminal domains defines a subset of
topoisomerases
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